B cell activating factor belonging to TNF superfamily (BAFF) is a critical regulator of B cell maturation and survival. In this present study, the expression characteristic of BAFF in kidney transplantation recipients was investigated, its potential significance was analyzed and peripheral blood of follow-up kidney transplant recipients was studied. Flow cytometric assay results showed that, cell-surface BAFF was significantly highly expressed on peripheral CD3 
Introduction
B cell activating factor belonging to TNF superfamily (BAFF, CD257), which is also termed BLys, TALL-1, zTNF4, THANK and TNFSF13, is a homotrimer, member of the TNF superfamily expressed on the cell surface or cleaved and secreted (1, 2) . BAFF specifically binds to BAFF receptor (BAFF-R, also known as BR3) (1, 2) , and BAFF can also bind to other two receptors, transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI) and B-cell maturation antigen (BCMA), shared with another TNF ligand, a proliferation-inducing ligand (APRIL) (1, 2) .
BAFF is expressed by monocyte-derived cells, such as monocytes, macrophages, dendritic cells, and activated T lymphocytes, which plays an important role in immune response. The discovery of BAFF has shed new light on the importance of finely tuned B cell survival for B cell tolerance during B cell maturation and activation (3) (4) (5) . Excessive production of BAFF is associated with the development of autoimmune diseases, because transgenic (Tg) mice that overproduce BAFF develop severe autoimmune disorders that resemble systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS) in humans, possibly as a result of improper B cell survival, predominantly affecting the maturing splenic transitional type 2 (T2) and the marginal zone (MZ) B cell populations (5-10). BAFF-induced autoimmunity in BAFF Tg mice appears to be highly dependent on B cells and possibly the production of autoantibodies (11) . High levels of BAFF have been found in the blood of patients with autoimmune diseases, particularly SLE and SS (10, (12) (13) (14) (15) . And BAFF was also found on T lymphocytes infiltrating labial salivary glands from patients with SS (16) . Now, there are few reports about BAFF and transplantation. Sarantopoulos et al. concluded that elevated BAFF levels contribute to B cell activation in patients with active chronic GVHD after having tested whether BAFF correlated with chronic GVHD (cGVHD) disease activity and time of onset after allogeneic hematopoietic stem cell transplantation (17) . Fujii et al. performed a concomitant analysis of a number of known and predicted peripheral blood cGVHD biomarkers from a Children's Oncology Group (COG) phase III cGVHD therapeutic trial, and found that soluble BAFF (sBAFF) was one of four biomarkers with high specificity and sensitivity on onset of cGVHD (18) .
These previous studies indicated that abnormal BAFF signaling may be not only involved in autoimmune diseases, but also involved in immunopathological course of acute or chronic allograft rejection. Immunologically mediated injury, including antibody-mediated or cellular-mediated mechanisms, is one of the major obstacles to gain long-term acceptance of renal allograft with minimal or no immunosuppression. In view of special bioactivity of BAFF, experiments have been carried through to explore the expression characteristic of BAFF and its potential bioactivity in renal allograft rejection, and some significant results were obtained.
Materials and Methods

Specimen collection
Sixty-nine recipients between Sep 2006 and Jan 2007 were studied. During our study, 13 healthy volunteers and 17 uremia patients treated by dialysis were controls. Peripheral blood was obtained from all of transplant patients and controls, anticoagulated by EDTA-Na 2 at room temperature (RT) for fluorescence-activating cell sorting (FACS) analysis and real-time reverse transcript-polymerase chain reaction (RT-PCR); the serum was stored at -20 o C after centrifuged at 250 g for 10 min for ELISA test.
Peripheral cell surface BAFF detection
The phenotypes, such as BAFF, CD3, CD4, and CD8 were examined using FACSCalibur (BD). Briefly, phycoerythrin (PE) conjugated anti-BAFF monoclonal antibody (eBioscience, San Diego, USA) was added into 100 l whole blood separately, with or without fluorescein isothiocyanate (FITC) conjugated anti-CD3, CD4, CD8, CD14 monoclonal antibodies (BD PharMingen, San Diego, USA), mixed, and reacted at 4 o C for 45 min. Then cell lysing solution (BD Bioscience, San Jose, CA, USA) was added, mixed adequately, and stilled for 15 min. Then all tubes were centrifuged at 250 g for 10 min, the supernatant was discarded and phosphate-buffered saline (PBS) was added, mixed and examined by FACSCalibur. The results were analyzed by BD CellQuest software.
Peripheral BAFF mRNA detection
The total mRNA of peripheral blood mononuclear cells (PBMC) of each volunteer was extracted by an SV Total RNA Isolation System kit (Promega, Madison, USA). The first-strand cDNA was obtained by using a Reverse Transcription System kit (Promega). Oligo 6.0 software (Molecular Biology Insights, Cascade, USA) was used to design primers of BAFF and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) ( Table 1 ). GAPDH gene expression was determined in separate tubes as control for the input cDNA. The mRNA levels of BAFF and GAPDH were measured by the LightCycler FastStart DNA Master SYBR Green I kit (Roche Diagnostics, Basel, Switzerland). PCR was carried out in a 20 l reaction mixture containing 2 l of 10× SYBR green buffer, 0.5 l of 5 U/l Taq, 2 l of 2.5 mM dNTP, 0. Sera sBAFF detection sBAFF in serum was tested by using human sBAFF ELISA kits (R&D Systems, Minneapolis, USA) according to the manufacturer's recommendations.
Sera anti-HLA I & II antibody detection
Titer of sera anti-HLA I & II antibody (Panel reactive antibody, PRA) was detected by Lambda antigen trays-mixed (One Lambda, CA, USA), according to instruction provided by the manufacturer. The BCIP staining results in each well of trays were read by ELX800NB under the wave of 630 nm.
Statistical analysis
The data were analyzed by one-way ANOVA or Student's t-test method with a statistical software package (SPSS version 10.0, SPSS, Chicago, USA). Statistical significance was defined as p values less than 0.05. All p values were two-sided.
Results
The expression characteristic and its statistical analysis of surface BAFF The flow cytometric results showed that the expression rate of BAFF was between 0.18%~76.97% on peripheral lymphocytes of kidney transplant recipients. BAFF expression could be found on CD3 + , CD4
+ and CD8 + T lymphocytes, and also Figure 1 .
To analyze the significance of BAFF expression, patients were stratified into three groups according to their post-transplant time: < 1 yrs (21 cases), 1-4 yrs (28 cases) and ≥ 5 yrs (20 cases). And the statistical results showed that BAFF expression was gradually increased accompanied with prolongation of transplantation. In ≥ 5 yrs group, mean expression rate of BAFF was 27.68%, with statistical significance compared to those of the healthy controls and uremia dialysis patients (p = 0.002 and 0.004, respectively) ( Figure 2 ).
All patients were also divided into two groups, according to their creatinine value: < 144 mol/L group (28 cases) and ≥ 144 mol/L group (41 cases) (< 144 mol/L is considered as normal value). In ≥ 144 mol/L group, the mean expression rate of BAFF on CD3 + T cells was 22.48%, while in < 144 mol/L group, the mean expression rate was 13.9% (p < 0.05) ( Table 2 ).
The expression characteristic and statistical analysis of BAFF mRNA
The real-time PCR results suggested that BAFF mRNA levels were rather weak in PBMC of kidney transplant recipients, and significantly increased along with prolongation of post-transplant. In 1-4 yrs group and ≥ 5 yrs group, there was statistical significance compared to healthy controls and uremia dialysis patients (p < 0.01) (Figure 3 ).
Concentration of sBAFF in serum
sBAFF were interindividually different in each patient of all the groups. The concentration of sBAFF was between 30.26-2,411.9 pg/ml, and there was no statistical significance between the groups (Figure 4 ).
Correlation analysis of PRA and BAFF expression level
The titers of PRA of some recipients increased significantly with the process of post-transplantation, and there was statistical significance between BAFF expression level and PRA titer (Table 3) .
Discussion
In the present study, FACS results indicated that, cell surface BAFF was abnormally highly expressed on peripheral T lymphocytes of some kidney transplant recipients, especially in those recipients for more than 5 yrs. The real-time PCR results showed that BAFF mRNA levels gradually increased along with the prolonged transplantation time, and BAFF mRNA levels were consistent with BAFF protein levels in different groups.
Expression of BAFF by T cells has been a controversial issue for some time with groups clearly detecting expression, particularly in activated cells, while several other studies were unable to show significant BAFF. The inadequate detection with currently available anti-BAFF monoclonal antibodies may have contributed to the relative difficulty in establishing BAFF protein production by T cells. Xu et al. reported that by using one monoclonal antibody (4F7) specially recognized human cell surface BAFF, abnormally high expression of BAFF was found on T lymphocytes from lung-cancer-associated pleural effusion (19) . And Lavie et al. found BAFF was expressed in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome by immunohistochemistry method with Buffy-2, one rat anti-human monoclonal antibody (16) . Here the mouse anti-human BAFF monoclonal antibody (1D6) was detected by FACS.
To investigate the correlation of transplant renal function and BAFF expression, transplant renal function was stratified and these data were statistically analyzed. In abnormal renal function group, BAFF was abnormally highly expressed on peripheral T lymphocytes, and the expression level was about as high as that in ≥ 5 yrs group. And there was statistically significant association between anti-HLA I & II antibodies level and BAFF expression level. Terasaki et al. analyzed the predictive value of anti-HLA antibody and outcome of kidney transplant (20) , and they also prospectively studied the correlation of anti-HLA concentration and serum creatinine in chronic rejection (21) . They found that increase of PRA level predicted the failure of kidney graft.
In the present study, the results indicated that BAFF expression was correlated with gradually decreasing transplant renal function, and BAFF may be involved in immune regulating network of kidney transplantation, which was the first report about BAFF and kidney transplantation. Then how does BAFF signaling act on allograft rejection of kidney transplantation?
Some researchers found that interaction between BAFF and its receptor on T cells enhance human T cell response to anti-CD3 activation (22) ; upon activation T cells produce BAFF and up-regulate BAFF-R on the surface. BAFF signaling via BAFF-R acts as a costimulator of T cell activation, an effect that may result in parting from increased basal survival. T cells then differentiate into effective cells preferentially producing Th1 cytokines (23) . And the BAFF on T cells may bind to BCMA on B cells providing more survival signal to increase basal survival of B cells, and resulting in more production of antibodies (24) . Is increase of Nardelli et al. reported that sBAFF is produced by enzymatic processing of the membrane-bound protein by conducting experiments with cells transfected with a mutant BAFF cDNA (25) , as suggested in Schneider's previous report (26) . Because the BAFF sequence does not contain a predicted signal peptide, a possible mechanism for the release of BAFF from the cells is the proteolytic cleavage of the membrane-bound protein. However, there is no correlation between the levels of cell surface-associated BAFF and the concentration of sBAFF found in the cultures (25) , and the results were in agreement with theirs. In this present study, there existed interindividual difference of cleaved BAFF levels (serum BAFF levels), and there was no statistical significance between different groups. And these results were different from observations on GVHD (17, 18) . Some factors in body fluid may affect the concentration and bioactivity of the proteolytic enzyme in kidney transplant recipients or stem cell transplant recipients. Further work is needed to understand the possible reason of serum BAFF formation conditions. .008
